Catalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome.
产品应用
应用
已检合格种属
预测种属
推荐稀释比例
WB
Human
1:500-2000
IHC-P
Human
1:50-200
IHC-F
Human
1:50-200
IF
Human
1:50-200
Flow-Cyt
Human
1:50-100
ICC/IF
Human
1:50-200
IP
Human
1:20-50
交叉反应
交叉反应: Human
相关产品
暂无相关产品
靶标
基因名
GLA
蛋白名
alpha-galactosidase A
亚基
Homodimer.
亚细胞定位
Lysosome.
疾病
Defects in GLA are the cause of Fabry disease (FD) [MIM:301500]. FD is a rare X-linked sphingolipidosis disease where glycolipid accumulates in many tissues. The disease consists of an inborn error of glycosphingolipid catabolism. FD patients show systemic accumulation of globotriaoslyceramide (Gb3) and related glycosphingolipids in the plasma and cellular lysosomes throughout the body. Clinical recognition in males results from characteristic skin lesions (angiokeratomas) over the lower trunk. Patients may show ocular deposits, febrile episodes, and burning pain in the extremities. Death results from renal failure, cardiac or cerebral complications of hypertension or other vascular disease. Heterozygous females may exhibit the disorder in an attenuated form, they are more likely to show corneal opacities.